MED.00139 Electrical Impedance Scanning for Cancer Detection

This policy addresses electrical impedance scanning (EIS) tests/devices for cancer detection, including the ProLung Test and IONIQ Breast Test. Anthem considers EIS for cancer detection investigational/experimental and not medically necessary; it is not covered for any indication. There are no covered circumstances or exceptions (applies to all cancers and clinical scenarios), and current devices do not have FDA approval.

"Electrical impedance scanning for cancer detection is consideredinvestigational and not medically necessaryfor all indications."

Sign up to see full coverage criteria, indications, and limitations.